173 related articles for article (PubMed ID: 38457262)
1. MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.
Ito K; Harada I; Martinez C; Sato K; Lee E; Port E; Byerly JH; Nayak A; Tripathi E; Zhu J; Irie HY
Cancer Res Commun; 2024 Mar; 4(3):946-957. PubMed ID: 38457262
[TBL] [Abstract][Full Text] [Related]
2. PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.
Ito K; Park SH; Nayak A; Byerly JH; Irie HY
Cancer Res; 2016 Aug; 76(15):4406-17. PubMed ID: 27302163
[TBL] [Abstract][Full Text] [Related]
3. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
Pai JT; Chen XH; Leu YL; Weng MS
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination and degradation of CFTR by the E3 ubiquitin ligase MARCH2 through its association with adaptor proteins CAL and STX6.
Cheng J; Guggino W
PLoS One; 2013; 8(6):e68001. PubMed ID: 23818989
[TBL] [Abstract][Full Text] [Related]
5. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
[TBL] [Abstract][Full Text] [Related]
6. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.
Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G
Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431
[TBL] [Abstract][Full Text] [Related]
7. MARCH2 regulates autophagy by promoting CFTR ubiquitination and degradation and PIK3CA-AKT-MTOR signaling.
Xia D; Qu L; Li G; Hongdu B; Xu C; Lin X; Lou Y; He Q; Ma D; Chen Y
Autophagy; 2016 Sep; 12(9):1614-30. PubMed ID: 27308891
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase RBX1 drives the metastasis of triple negative breast cancer through a FBXO45-TWIST1-dependent degradation mechanism.
Shao J; Feng Q; Jiang W; Yang Y; Liu Z; Li L; Yang W; Zou Y
Aging (Albany NY); 2022 Jul; 14(13):5493-5510. PubMed ID: 35802537
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin ligase MARCH2 regulates ERGIC3-dependent trafficking of secretory proteins.
Yoo W; Cho EB; Kim S; Yoon JB
J Biol Chem; 2019 Jul; 294(28):10900-10912. PubMed ID: 31142615
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
[TBL] [Abstract][Full Text] [Related]
11. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
12. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
[TBL] [Abstract][Full Text] [Related]
13. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2.
Chathuranga K; Kim TH; Lee H; Park JS; Kim JH; Chathuranga WAG; Ekanayaka P; Choi YJ; Lee CH; Kim CJ; Jung JU; Lee JS
EMBO J; 2020 Nov; 39(21):e105139. PubMed ID: 32935379
[TBL] [Abstract][Full Text] [Related]
15. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells.
Zeng D; Liang YK; Xiao YS; Wei XL; Lin HY; Wu Y; Bai JW; Chen M; Zhang GJ
Int J Cancer; 2020 Jul; 147(2):490-504. PubMed ID: 32020593
[TBL] [Abstract][Full Text] [Related]
18. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
[TBL] [Abstract][Full Text] [Related]
19. Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT.
Zheng Y; Jia H; Wang P; Liu L; Chen Z; Xing X; Wang J; Tan X; Wang C
Cancer Gene Ther; 2023 Jan; 30(1):74-84. PubMed ID: 36064576
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition.
Das K; Paul S; Singh A; Ghosh A; Roy A; Ansari SA; Prasad R; Mukherjee A; Sen P
J Biol Chem; 2019 Sep; 294(37):13681-13696. PubMed ID: 31341019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]